Genetics of osteoporosis

Biochemical and Biophysical Research Communications

Volumn 452, Issue 2, 2014, Pages 287-293

  Urano, Tomohiko ^a   Inoue, Satoshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone mineral density (BMD); Genome wide association study (GWAS); Osteoporosis; Single nucleotide polymorphism (SNP); WNT catenin signaling

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETA CATENIN; CELL NUCLEUS RECEPTOR; WNT PROTEIN; CELL RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

BONE DENSITY; BONE METABOLISM; FRAGILITY FRACTURE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; MEDICAL GENETICS; NONHUMAN; OSTEOPOROSIS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY; BONE MINERAL DENSITY (BMD); GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY (GWAS); RADIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM (SNP); WNT-Β-CATENIN SIGNALING;

BONE MINERAL DENSITY (BMD); GENOME-WIDE ASSOCIATION STUDY (GWAS); OSTEOPOROSIS; SINGLE NUCLEOTIDE POLYMORPHISM (SNP); WNT-Β-CATENIN SIGNALING;

BONE DENSITY; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; WNT PROTEINS;

EID: 84908619022     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.141     Document Type: Review

References (83)

1. NIH Consens Statement, Osteoporosis prevention, diagnosis, and therapy, 17 (2000) 1-45.
2. B. Dawson-Hughes, National Osteoporosis Foundation Guide Committee, A revised clinician's guide to the prevention and treatment of osteoporosis, J. Clin. Endocrinol. Metab. 93 (2008) 2463-2465.
3. L. Flicker, J.L. Hopper, L. Rodgers, B. Kaymakci, R.M. Green, J.D. Wark, Bone density determinants in elderly women: a twin study, J. Bone Miner. Res. 10 (1995) 1607-1613.
4. D.M. Smith, W.E. Nance, K.W. Kang, J.C. Christian, C.C. Johnston Jr., Genetic factors in determining bone mass, J. Clin. Invest. 52 (1973) 2800-2808.
5. D. Young, J.L. Hopper, C.A. Nowson, R.M. Green, A.J. Sherwin, B. Kaymakci, M. Smid, C.S. Guest, R.G. Larkins, J.D. Wark, Determinants of bone mass in 10- to 26-year-old females: a twin study, J. Bone Miner. Res. 10 (1995) 558-567.
6. D.A. Nelson, M. Kleerekoper, The search for the osteoporosis gene, J. Clin. Endocrinol. Metab. 82 (1997) 989-990.
7. N.A. Morrison, J.C. Qi, A. Tokita, P.J. Kelly, L. Crofts, T.V. Nguyen, P.N. Sambrook, J.A. Eisman, Prediction of bone density from vitamin D receptor alleles, Nature 367 (1994) 284-287.
8. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, S.H. Selznick, C.E. Dominguez, P.W. Jurutka, The nuclear vitamin D receptor: biological and molecular regulatory properties revealed, J. Bone Miner. Res. 13 (1998) 325-349.
9. L. Gennari, D. Merlotti, V. De Paola, G. Martini, R. Nuti, Update on the pharmacogenetics of the vitamin D receptor and osteoporosis, Pharmacogenomics 10 (2009) 417-433.
10. G.S. Cooper, D.M. Umbach, Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis, J. Bone Miner. Res. 11 (1996) 1841-1849.
11. G. Gong, H.S. Stern, S.C. Cheng, N. Fong, J. Mordeson, H.W. Deng, R.R. Recker, The association of bone mineral density with vitamin D receptor gene polymorphisms, Osteoporos. Int. 9 (1999) 55-64.
12. A. Thakkinstian, C. D'Este, J. Eisman, T. Nguyen, J. Attia, Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study, J. Bone Miner. Res. 19 (2004) 419-428.
13. S.H. Tella, J.C. Gallagher, Prevention and treatment of postmenopausal osteoporosis, J. Steroid Biochem. Mol. Biol. 142C (2014) 155-170.
14. S. Green, P. Walter, V. Kumar, A. Krust, J.M. Bornert, P. Argos, P. Chambon, Human oestrogen receptor cDNA: sequence, expression and homology to verb-A, Nature 320 (1986) 134-139.
15. G.L. Greene, P. Gilna, M. Waterfield, A. Baker, Y. Hort, J. Shine, Sequence and expression of human estrogen receptor complementary DNA, Science 231 (1986) 1150-1154.
16. S. Koike, M. Sakai, M. Muramatsu, Molecular cloning and characterization of rat estrogen receptor cDNA, Nucleic Acids Res. 15 (1987) 2499-2513.
17. G.G. Kuiper, J.A. Gustafsson, The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens, FEBS Lett. 410 (1997) 87-90.
18. S. Mosselman, J. Polman, R. Dijkema, ER beta: identification and characterization of a novel human estrogen receptor, FEBS Lett. 392 (1996) 49-53.
19. K. Lee, H. Jessop, R. Suswillo, G. Zaman, L. Lanyon, Endocrinology: bone adaptation requires oestrogen receptor-alpha, Nature 424 (2003) 389.
20. H.L. Jessop, R.F. Suswillo, S.C. Rawlinson, G. Zaman, K. Lee, V. Das-Gupta, A.A. Pitsillides, L.E. Lanyon, Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain, J. Bone Miner. Res. 19 (2004) 938-946.
21. L. Gennari, D. Merlotti, V. De Paola, A. Calabrò, L. Becherini, G. Martini, R. Nuti, Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review, Am. J. Epidemiol. 161 (2005) 307-320.
22. M. Sano, S. Inoue, T. Hosoi, Y. Ouchi, M. Emi, M. Shiraki, H. Orimo, Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis, Biochem. Biophys. Res. Commun. 217 (1995) 378-383.
23. S. Kobayashi, S. Inoue, T. Hosoi, Y. Ouchi, M. Shiraki, H. Orimo, Association of bone mineral density with polymorphism of the estrogen receptor gene, J. Bone Miner. Res. 11 (1996) 306-311.
24. L. Gennari, V. De Paola, D. Merlotti, G. Martini, R. Nuti, Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review, Expert Opin. Pharmacother. 8 (2007) 537-553.
25. D.M. Herrington, E. Vittinghoff, F. Lin, J. Fong, F. Harris, D. Hunninghake, V. Bittner, H.G. Schrott, R.S. Blumenthal, R. Levy, HERS Study Group, Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS), Circulation 105 (2002) 2962-2967.
26. S. Iwashita, K. Koyama, Y. Nakamura, VNTR sequence on human chromosome 11p15 that affects transcriptional activity, J. Hum. Genet. 46 (2001) 717-721.
27. H. Clevers, Wnt/beta-catenin signaling in development and disease, Cell 127 (2006) 469-480.
28. H. Huang, X. He, Wnt/beta-catenin signaling: new (and old) players and new insights, Curr. Opin. Cell Biol. 20 (2008) 119-125.
29. B.T. MacDonald, K. Tamai, X. He, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev. Cell 17 (2009) 9-26.
30. Y. Gong, R.B. Slee, N. Fukai, G. Rawadi, S. Roman-Roman, A.M. Reginato, H. Wang, T. Cundy, F.H. Glorieux, D. Lev, M. Zacharin, K. Oexle, J. Marcelino, W. Suwairi, S. Heeger, G. Sabatakos, S. Apte, W.N. Adkins, J. Allgrove, M. Arslan-Kirchner, J.A. Batch, P. Beighton, G.C. Black, R.G. Boles, L.M. Boon, C. Borrone, H.G. Brunner, G.F. Carle, B. Dallapiccola, A. De Paepe, B. Floege, M.L. Halfhide, B. Hall, R.C. Hennekam, T. Hirose, A. Jans, H. Jüppner, C.A. Kim, K. Keppler-Noreuil, A. Kohlschuetter, D. LaCombe, M. Lambert, E. Lemyre, T. Letteboer, L. Peltonen, R.S. Ramesar, M. Romanengo, H. Somer, E. Steichen-Gersdorf, B. Steinmann, B. Sullivan, A. Superti-Furga, W. Swoboda, M.J. van den Boogaard, W. Van Hul, M. Vikkula, M. Votruba, B. Zabel, T. Garcia, R. Baron, B.R. Olsen, M.L. Warman, Osteoporosis-Pseudoglioma Syndrome Collaborative Group, LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, Cell 107 (2001) 513-523.
31. L.M. Boyden, J. Mao, J. Belsky, L. Mitzner, A. Farhi, M.A. Mitnick, D. Wu, K. Insogna, R.P. Lifton, High bone density due to a mutation in LDL-receptor-related protein 5, N. Engl. J. Med. 346 (2002) 1513-1521.
32. R.D. Little, J.P. Carulli, R.G. Del Mastro, J. Dupuis, M. Osborne, C. Folz, S.P. Manning, P.M. Swain, S.C. Zhao, B. Eustace, M.M. Lappe, L. Spitzer, S. Zweier, K. Braunschweiger, Y. Benchekroun, X. Hu, R. Adair, L. Chee, M.G. FitzGerald, C. Tulig, A. Caruso, N. Tzellas, A. Bawa, B. Franklin, S. McGuire, X. Nogues, G. Gong, K.M. Allen, A. Anisowicz, A.J. Morales, P.T. Lomedico, S.M. Recker, P. Van Eerdewegh, R.R. Recker, M.L. Johnson, A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait, Am. J. Hum. Genet. 70 (2002) 11-19.
33. S.L. Ferrari, S. Deutsch, S.E. Antonarakis, Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass, Curr. Opin. Lipidol. 16 (2005) 207-214.
34. R. Baron, G. Rawadi, S. Roman-Roman, Wnt signaling: a key regulator of bone mass, Curr. Top. Dev. Biol. 76 (2006) 103-127.
35. T. Urano, M. Shiraki, Y. Ezura, M. Fujita, E. Sekine, S. Hoshino, T. Hosoi, H. Orimo, M. Emi, Y. Ouchi, S. Inoue, Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density, J. Bone Miner. Metab. 22 (2004) 341-345.
36. Y. Ezura, T. Nakajima, T. Urano, Y. Sudo, M. Kajita, H. Yoshida, T. Suzuki, T. Hosoi, S. Inoue, M. Shiraki, M. Emi, Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women, Bone 40 (2007) 997-1005.
37. T. Mizuguchi, I. Furuta, Y. Watanabe, K. Tsukamoto, H. Tomita, M. Tsujihata, T. Ohta, T. Kishino, N. Matsumoto, H. Minakami, N. Niikawa, K. Yoshiura, LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density, J. Hum. Genet. 49 (2004) 80-86.
38. J. Bollerslev, S.G. Wilson, I.M. Dick, F.M. Islam, T. Ueland, L. Palmer, A. Devine, R.L. Prince, LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women, Bone 36 (2005) 599-606.
39. S.L. Ferrari, S. Deutsch, C. Baudoin, M. Cohen-Solal, A. Ostertag, S.E. Antonarakis, R. Rizzoli, M.C. de Vernejoul, LRP5 gene polymorphisms and idiopathic osteoporosis in men, Bone 37 (2005) 770-775.
40. J.B. van Meurs, F. Rivadeneira, M. Jhamai, W. Hugens, A. Hofman, J.P. van Leeuwen, H.A. Pols, A.G. Uitterlinden, Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men, J. Bone Miner. Res. 21 (2006) 141-150.
41. A. Saarinen, V.V. Välimäki, M.J. Välimäki, E. Löyttyniemi, K. Auro, P. Uusen, M. Kuris, A.E. Lehesjoki, O. Mäkitie, The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men, Bone 40 (2007) 1006-1112.
42. S. Giroux, L. Elfassihi, G. Cardinal, N. Laflamme, F. Rousseau, LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women, Bone 40 (2007) 1299-1307.
43. J.B. van Meurs, T.A. Trikalinos, S.H. Ralston, S. Balcells, M.L. Brandi, K. Brixen, D.P. Kiel, B.L. Langdahl, P. Lips, O. Ljunggren, R. Lorenc, B. Obermayer-Pietsch, C. Ohlsson, U. Pettersson, D.M. Reid, F. Rousseau, S. Scollen, W. Van Hul, L. Agueda, K. Akesson, L.I. Benevolenskaya, S.L. Ferrari, G. Hallmans, A. Hofman, L.B. Husted, M. Kruk, S. Kaptoge, D. Karasik, M.K. Karlsson, M. Lorentzon, L. Masi, F.E. McGuigan, D. Mellström, L. Mosekilde, X. Nogues, H.A. Pols, J. Reeve, W. Renner, F. Rivadeneira, N.M. van Schoor, K. Weber, J.P. Ioannidis, Uitterlinden AG; GENOMOS Study. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis, JAMA 299 (2008) 1277-1290.
44. J.B. Richards, F. Rivadeneira, M. Inouye, T.M. Pastinen, N. Soranzo, S.G. Wilson, T. Andrew, M. Falchi, R. Gwilliam, K.R. Ahmadi, A.M. Valdes, P. Arp, P. Whittaker, D.J. Verlaan, M. Jhamai, V. Kumanduri, M. Moorhouse, J.B. van Meurs, A. Hofman, H.A. Pols, D. Hart, G. Zhai, B.S. Kato, B.H. Mullin, F. Zhang, P. Deloukas, A.G. Uitterlinden, T.D. Spector, Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, Lancet 371 (2008) 1505-1512.
45. T. Urano, M. Shiraki, T. Usui, N. Sasaki, Y. Ouchi, S. Inoue, A1330V variant of the low-density lipoprotein receptor-related protein 5 (LRP5) gene decreases Wnt signaling and affects the total body bone mineral density in Japanese women, Endocr. J. 56 (2009) 625-631.
46. S.L. Ferrari, S. Deutsch, U. Choudhury, T. Chevalley, J.P. Bonjour, E.T. Dermitzakis, R. Rizzoli, S.E. Antonarakis, Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites, Am. J. Hum. Genet. 74 (2004) 866-875.
47. J.M. Koh, M.H. Jung, J.S. Hong, H.J. Park, J.S. Chang, H.D. Shin, S.Y. Kim, G.S. Kim, Association between bone mineral density and LDL receptor-related protein 5 polymorphisms in young Korean men, J. Korean Med. Sci. 19 (2004) 407-412.
48. Z.L. Zhang, Y.J. Qin, J.W. He, Q.R. Huang, M. Li, Y.Q. Hu, Y.J. Liu, Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women, Acta Pharmacol. Sin. 26 (2005) 1111-1116.
49. T. Urano, M. Shiraki, K. Narusawa, T. Usui, N. Sasaki, T. Hosoi, Y. Ouchi, T. Nakamura, S. Inoue, Q89R polymorphism in the LDL receptor-related protein 5 gene is associated with spinal osteoarthritis in postmenopausal Japanese women, Spine 32 (2007) 25-29.
50. R. Reilly, H. McNulty, K. Pentieva, J.J. Strain, M. Ward, MTHFR 677TT genotype and disease risk: is there a modulating role for B-vitamins?, Proc Nutr. Soc. 73 (2014) 47-56.
51. M. Devoto, C. Specchia, H.H. Li, J. Caminis, A. Tenenhouse, H. Rodriguez, L.D. Spotila, Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36, Hum. Mol. Genet. 10 (2001) 2447-2452.
52. L.D. Spotila, H. Rodriguez, M. Koch, H.S. Tenenhouse, A. Tenenhouse, H. Li, M. Devoto, Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36, Calcif. Tissue Int. 73 (2003) 140-146.
53. C.G. Gjesdal, S.E. Vollset, P.M. Ueland, H. Refsum, H.E. Meyer, G.S. Tell, Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study, J. Bone Miner. Res. 22 (2007) 747-756.
54. J.B. van Meurs, R.A. Dhonukshe-Rutten, S.M. Pluijm, M. van der Klift, R. de Jonge, J. Lindemans, L.C. de Groot, A. Hofman, J.C. Witteman, J.P. van Leeuwen, M.M. Breteler, P. Lips, H.A. Pols, A.G. Uitterlinden, Homocysteine levels and the risk of osteoporotic fracture, N. Engl. J. Med. 350 (2004) 2033-2041.
55. R.R. McLean, P.F. Jacques, J. Selhub, K.L. Tucker, E.J. Samelson, K.E. Broe, M.T. Hannan, L.A. Cupples, D.P. Kiel, Homocysteine as a predictive factor for hip fracture in older persons, N. Engl. J. Med. 350 (2004) 2042-2049.
56. B. Lubec, S. Fang-Kircher, T. Lubec, H.J. Blom, G.H. Boers, Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria, Biochim. Biophys. Acta 1315 (1996) 159-162.
57. M. Saito, K. Fujii, K. Marumo, Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls, Calcif. Tissue Int. 79 (2006) 160-168.
58. M. Herrmann, J. Peter Schmidt, N. Umanskaya, A. Wagner, O. Taban-Shomal, T. Widmann, G. Colaianni, B. Wildemann, W. Herrmann, The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review, Clin. Chem. Lab. Med. 45 (2007) 1621-1632.
59. R. Bai, W. Liu, A. Zhao, Z. Zhao, D. Jiang, Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis, Mol. Biol. Rep. 40 (2013) 2419-2430.
60. M. Shiraki, T. Urano, T. Kuroda, M. Saito, S. Tanaka, M. Miyao-Koshizuka, S. Inoue, The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures, J. Bone Miner. Metab. 26 (2008) 595-602.
61. J.N. Hirschhorn, M.J. Daly, Genome-wide association studies for common diseases and complex traits, Nat. Rev. Genet. 6 (2005) 95-108.
62. K. Wang, M. Li, H. Hakonarson, Analysing biological pathways in genome-wide association studies, Nat. Rev. Genet. 11 (2010) 843-854.
63. T.V. Nguyen, J.R. Center, J.A. Eisman, Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy, Curr. Opin. Endocrinol. Diabetes Obes. 15 (2008) 481-488.
64. X.H. Xu, S.S. Dong, Y. Guo, T.L. Yang, S.F. Lei, C.J. Papasian, M. Zhao, H.W. Deng, Molecular genetic studies of gene identification for osteoporosis: the 2009 update, Endocr. Rev. 31 (2010) (2009) 447-505.
65. S.H. Ralston, A.G. Uitterlinden, Genetics of osteoporosis, Endocr. Rev. 31 (2010) 629-662.
66. D.P. Kiel, S. Demissie, J. Dupuis, K.L. Lunetta, J.M. Murabito, D. Karasik, Genome-wide association with bone mass and geometry in the Framingham Heart Study, BMC Med. Genet. 8 (2007) S14.
67. U. Styrkarsdottir, B.V. Halldorsson, S. Gretarsdottir, D.F. Gudbjartsson, G.B. Walters, T. Ingvarsson, T. Jonsdottir, J. Saemundsdottir, J.R. Center, T.V. Nguyen, Y. Bagger, J.R. Gulcher, J.A. Eisman, C. Christiansen, G. Sigurdsson, A. Kong, U. Thorsteinsdottir, K. Stefansson, Multiple genetic loci for bone mineral density and fractures, N. Engl. J. Med. 358 (2008) 2355-2365.
68. U. Styrkarsdottir, B.V. Halldorsson, S. Gretarsdottir, D.F. Gudbjartsson, G.B. Walters, T. Ingvarsson, T. Jonsdottir, J. Saemundsdottir, S. Snorradóttir, J.R. Center, T.V. Nguyen, P. Alexandersen, J.R. Gulcher, J.A. Eisman, C. Christiansen, G. Sigurdsson, A. Kong, U. Thorsteinsdottir, K. Stefansson, New sequence variants associated with bone mineral density, Nat. Genet. 41 (2009) 15-17.
69. D.H. Xiong, X.G. Liu, Y.F. Guo, L.J. Tan, L. Wang, B.Y. Sha, Z.H. Tang, F. Pan, T.L. Yang, X.D. Chen, S.F. Lei, L.M. Yerges, X.Z. Zhu, V.W. Wheeler, A.L. Patrick, C.H. Bunker, Y. Guo, H. Yan, Y.F. Pei, Y.P. Zhang, S. Levy, C.J. Papasian, P. Xiao, Y.W. Lundberg, R.R. Recker, Y.Z. Liu, Y.J. Liu, J.M. Zmuda, H.W. Deng, Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups, Am. J. Hum. Genet. 84 (2009) 388-398.
70. Y.S. Cho, M.J. Go, Y.J. Kim, J.Y. Heo, J.H. Oh, H.J. Ban, D. Yoon, M.H. Lee, D.J. Kim, M. Park, S.H. Cha, J.W. Kim, B.G. Han, H. Min, Y. Ahn, M.S. Park, H.R. Han, H.Y. Jang, E.Y. Cho, J.E. Lee, N.H. Cho, C. Shin, T. Park, J.W. Park, J.K. Lee, L. Cardon, G. Clarke, M.I. McCarthy, J.Y. Lee, J.K. Lee, B. Oh, H.L. Kim, A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits, Nat. Genet. 41 (2009) 527-534.
71. F. Rivadeneira, U. Styrkársdottir, K. Estrada, B.V. Halldórsson, Y.H. Hsu, J.B. Richards, M.C. Zillikens, F.K. Kavvoura, N. Amin, Y.S. Aulchenko, L.A. Cupples, P. Deloukas, S. Demissie, E. Grundberg, A. Hofman, A. Kong, D. Karasik, J.B. van Meurs, B. Oostra, T. Pastinen, H.A. Pols, G. Sigurdsson, N. Soranzo, G. Thorleifsson, U. Thorsteinsdottir, F.M. Williams, S.G. Wilson, Y. Zhou, S.H. Ralston, C.M. van Duijn, T. Spector, D.P. Kiel, K. Stefansson, J.P. Ioannidis, A.G. Uitterlinden, Genetic Factors for Osteoporosis (GEFOS) Consortium, Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies, Nat. Genet. 41 (2009) 1199-1206.
72. A.W. Kung, S.M. Xiao, S. Cherny, G.H. Li, Y. Gao, G. Tso, K.S. Lau, K.D. Luk, J.M. Liu, B. Cui, M.J. Zhang, Z.L. Zhang, J.W. He, H. Yue, W.B. Xia, L.M. Luo, S.L. He, D.P. Kiel, D. Karasik, Y.H. Hsu, L.A. Cupples, S. Demissie, U. Styrkarsdottir, B.V. Halldorsson, G. Sigurdsson, U. Thorsteinsdottir, K. Stefansson, J.B. Richards, G. Zhai, N. Soranzo, A. Valdes, T.D. Spector, P.C. Sham, Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies, Am. J. Hum. Genet. 86 (2010) 229-239.
73. T. Urano, M. Shiraki, T. Usui, N. Sasaki, Y. Ouchi, S. Inoue, Identification of non-synonymous polymorphisms in the WDSOF1 gene as novel susceptibility markers for low bone mineral density in Japanese postmenopausal women, Bone 47 (2010) 636-642.
74. I. Kou, A. Takahashi, T. Urano, N. Fukui, H. Ito, K. Ozaki, T. Tanaka, T. Hosoi, M. Shiraki, S. Inoue, Y. Nakamura, N. Kamatani, M. Kubo, S. Mori, S. Ikegawa, Common variants in a novel gene, FONG on chromosome 2q33.1 confer risk of osteoporosis in Japanese, PLoS One 6 (2011) e19641.
75. T. Urano, M. Shiraki, H. Yagi, M. Ito, N. Sasaki, M. Sato, Y. Ouchi, S. Inoue, GPR98/Gpr98 gene is involved in the regulation of human and mouse bone mineral density, J. Clin. Endocrinol. Metab. 97 (2012) E565-74.
76. J.B. Richards, H.F. Zheng, T.D. Spector, Genetics of osteoporosis from genome-wide association studies: advances and challenges, Nat. Rev. Genet. 13 (2012) 576-588.
77. A.P. Trouvin, V. Goëb, Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss, Clin. Interv. Aging 5 (2010) 345-354.
78. A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, European Working Group on Sarcopenia in Older People, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing 39 (2010) 412-423.
79. T. Urano, M. Shiraki, N. Sasaki, Y. Ouchi, S. Inoue, Large-scale analysis reveals a functional single-nucleotide polymorphism in the 5′-flanking region of PRDM16 gene associated with lean body mass, Aging Cell 13 (2014) 739-744.
80. P. Seale, B. Bjork, W. Yang, S. Kajimura, S. Chin, S. Kuang, A. Scimè, S. Devarakonda, H.M. Conroe, H. Erdjument-Bromage, P. Tempst, M.A. Rudnicki, D.R. Beier, B.M. Spiegelman, PRDM16 controls a brown fat/skeletal muscle switch, Nature 454 (2008) 961-967.
81. T. Miyazaki, F. Tokimura, S. Tanaka, A review of denosumab for the treatment of osteoporosis, Patient Prefer. Adherence 8 (2014) 463-471.
82. M. Rossini, D. Gatti, S. Adami, Involvement of WNT/β-catenin signaling in the treatment of osteoporosis, Calcif. Tissue Int. 93 (2013) 121-132.
83. P.M. Giguere, W.K. Kroeze, B.L. Roth, Tuning up the right signal: chemical and genetic approaches to study GPCR functions, Curr. Opin. Cell Biol. 27 (2014) 51-55.